Upcoming Webinar
How Funders Feel About AI, and What Keeps Them Saying Yes.
Wed, Oct 14 @ 2PM ET

Skip to main content
Main content

Best Alzheimer's and Dementia Research Grants

Get funding for Alzheimer's and dementia research, caregiver support, clinical trials, public awareness, and early detection initiatives.

119

Available grants

$26.6M

Total funding

$75K

Median grant

119 grants
$26.6M total
$75K median

Skip the search. Get matched with grants that fit your non-profit.

Skip the search.

Get matched with grants that actually fit.

Smart recommendations based on your profile — in minutes.

Find me grants
Last updated: October 5, 2026. Next update: November 1, 2026.

AI summary from publicly available grant information

Up to US $60,000

Hawaii Community Foundation: Medical Research Grants

Applications due Dec 13, 2026
The Hawai‘i Community Foundation (HCF) offers Medical Research Grants to support vital basic and clinical research conducted locally. Aimed at enhancing the medical research community in Hawai‘i, the program focuses on various health issues, including cancer, heart disease, and diabetes. Additionally, it fosters research infrastructure to bolster research capacity. Funded by multiple sources, including the Leahi Fund and the George F. Straub Trust, these grants are essential for advancing healthcare and scientific discovery in the region.
Hawai'i Community Foundation

US $200,000 - US $300,000

Alzheimer's Disease Research Grants

Applications due Sep 1, 2027
BrightFocus Foundation offers Alzheimer's Disease Research Grants to support innovative research aimed at understanding, preventing, and treating Alzheimer's disease. These grants encourage applications from diverse backgrounds, fostering creativity in scientific research. The program includes Standard Awards for early investigators with a maximum funding of $300,000 for three years and Postdoctoral Fellowship Awards for young researchers at $200,000 for two years, promoting the development of independent research careers.
BrightFocus Foundation

Up to US $210,000

A. P. Giannini Foundation: Postdoctoral Research Fellowship and Leadership Award

Applications due Nov 5, 2026
The A.P. Giannini Foundation offers a Postdoctoral Research Fellowship and Leadership Award to support innovative biomedical research. Since 1945, the Foundation has funded nearly $50 million in research aimed at translating scientific discoveries into effective treatments for various diseases. This fellowship program not only provides financial support but also includes leadership training and a collaborative learning community, preparing fellows for impactful careers in academia and industry.
A P Giannini Foundation

Skip the search.

Get matched with grants that actually fit.

Smart recommendations based on your profile — in minutes.

US $5,000 - US $50,000

Barney Family Foundation Grant

Applications due Jun 30, 2027
The Barney Family Foundation Grant focuses on improving early education and advancing medical research, particularly in cancer and Alzheimer’s. It supports organizations that demonstrate a clear plan to enhance children's life experiences and educational opportunities for those in grades K-8. Grants typically range from $5,000 to $50,000, prioritizing established entities while welcoming startups. Eligible applicants must have 501(c)(3) status, and the Foundation does not fund individual requests or political activities.
Barney Family Foundation

Up to US $600,000

RFP- Neuroimaging and CSF Biomarker Program

Letter of inquiry due Sep 15, 2027
The RFP from the Alzheimer's Drug Discovery Foundation aims to develop crucial biomarkers for Alzheimer's and related dementias. Key focuses include creating novel PET ligands, supporting CSF biomarkers, and validating MRI techniques. The initiative prioritizes innovative biomarkers of neuroinflammation and synaptic integrity, emphasizing those that aid in early detection, disease progression monitoring, and differentiation between dementia subtypes, ultimately enhancing drug development and clinical applications.
Alzheimers Drug Discovery Foundation

Up to US $5,000,000

Prevention RFP

Full proposal due Dec 7, 2026
The Alzheimer’s Drug Discovery Foundation (ADDF) invites research proposals for precision prevention studies and combination therapy studies aimed at reducing the risk of Alzheimer’s disease and other dementias. The focus is on innovative interventions targeting specific risk factors, with an emphasis on clinical populations without dementia symptoms but with risk factors. Studies may explore novel drug mechanisms and combination therapies, particularly those with potential for preventing dementia through modifiable risk factors.
Alzheimers Drug Discovery Foundation

US $300,000 - US $350,000

RFP: Accelerating Drug Discovery For Frontotemporal Degeneration

Letter of inquiry due May 13, 2027
The Alzheimer's Drug Discovery Foundation (ADDF) seeks innovative proposals to accelerate drug development for frontotemporal dementia (FTD), a condition lacking FDA-approved treatments. The RFP encourages research into small molecules and biologics targeting key mechanisms behind FTD. With an average award of $300,000-$350,000 for a one-year duration, the initiative prioritizes lead optimization and in vivo testing of promising compounds. Collaborations with academic institutions and biotech firms are encouraged to enhance the potential for impactful therapeutic solutions.
Alzheimers Drug Discovery Foundation

Up to US $600,000

ADDF-Harrington Scholar Program

Letter of inquiry due Jun 8, 2027
The ADDF-Harrington Scholar Program aims to transform academic discoveries into effective treatments for Alzheimer’s disease and related dementias. With funding of up to $600,000 annually, this program prioritizes innovative drug targets and supports research from hit-to-lead optimization to IND-enabling studies. Eligible applicants include academic investigators with a strong potential to advance meaningful therapeutics. The program emphasizes collaboration with industry experts, making it a significant opportunity for advancing dementia research.
Alzheimers Drug Discovery Foundation

Up to US $500,000

CART Fund Grant

Letter of inquiry due Dec 5, 2026
The CART Fund Grant supports innovative Alzheimer’s Disease research projects in the U.S. with funding up to $500,000 for a two-year period. It invites full-time faculty from public and private institutions to submit Letters of Intent, emphasizing novel concepts that advance biomedical knowledge. Selected finalists will be invited to apply for standard grants. The initiative aims to foster groundbreaking research initiatives lacking extensive preliminary data, ensuring a focus on projects with transformative potential.
CART Fund

Up to US $50,000

AWARE Fund Grant

Applications due Mar 1, 2027
The AWARE Fund Grant, established by the Dallas Foundation, supports nonprofit organizations dedicated to combating Alzheimer’s disease in the North Texas area. With over $13 million raised since 1989, AWARE offers crucial funding for programs, research, and resources for caregivers. Eligible applicants must be nonprofit organizations in good financial health, with grants available up to $50,000. This initiative emphasizes the importance of community support in the ongoing fight against Alzheimer’s disease.
Dallas Foundation A Tx Nonprofit Corporation

US $20,000

Alzheimer’s Caregiving Innovation Funding from Family Caregiver Alliance

Applications due Oct 20, 2026
Not-for-profit organizations, government agencies, and universities in the U.S. with existing programs for family or informal caregivers of adults with Alzheimer’s and related dementias can receive US $20,000 awards for completed work. Family Caregiver Alliance honors innovative efforts in creative expression, increasing access and reducing stigma, and public policy that support dementia caregiving.
Family Caregiver Alliance

Up to US $750,000

MIHEF Healthy Aging RFP

Pre proposal due Mar 30, 2027
The MIHEF Healthy Aging RFP aims to enhance the health and wellness of Michigan's older adults and caregivers by funding innovative projects. It emphasizes priority areas such as Alzheimer's care, elder justice, caregiving support, and improved access to healthcare services. The initiative encourages concept paper submissions for feedback, fostering collaboration among organizations and healthcare providers to improve care quality and reduce costs. This approach seeks to ensure that older adults can maintain their independence and quality of life.
Michigan Health Endowment Fund

Up to US $600,000

Establishing a Research Network to Guide Foundational Research on Human Consciousness

Applications due Feb 8, 2027
The NIH Blueprint for Neuroscience Research Network aims to enhance foundational research on human consciousness, addressing critical biomedical issues such as coma and dementia. By fostering a collaborative framework among 14 NIH institutes, the initiative seeks to improve diagnosis and treatment of neurological disorders through interdisciplinary approaches. Key objectives include detecting consciousness in minimally responsive patients, enhancing understanding of sleep disorders, and exploring new methodologies. This effort will ultimately strengthen U.S. leadership in neuroscience and improve patient outcomes.
US Dept. of Health & Human Services: National Institutes of Health (NIH)

Up to US $500,000

Alzheimer’s Association World Wide FINGERS Network Funding Program (ALZ WW-FNFP)

Full proposal due Dec 21, 2026
The Alzheimer’s Association World Wide FINGERS Network Funding Program (ALZ WW-FNFP) supports global research on dementia risk reduction through multi-domain lifestyle interventions. Open to U.S. and international researchers within the WW-FINGERS Network, this program offers competitive funding up to $1,000,000 for projects lasting up to three years. Proposals will be evaluated based on their potential to enhance studies aimed at cognitive decline prevention, ensuring diverse approaches across various settings.
Alzheimer's Association

US $750,000

MIND Prize

Full proposal due Dec 17, 2026
The MIND Prize, funded by The Pershing Square Foundation, supports innovative research to combat neurodegenerative diseases like Alzheimer's. It empowers early-to-mid-career investigators to explore unconventional approaches and fosters collaboration across disciplines. Each winner receives $250,000 annually for three years, promoting advancements in neuroscience and creating a unique network for researchers. The initiative aims to enhance our understanding of brain health and tackle pressing societal challenges.
The Pershing Square Foundation

Up to US $100,000

FRAXA Fellowships

Applications due Feb 2, 2027
FRAXA Fellowships aim to accelerate the discovery of effective treatments for Fragile X syndrome, offering $50,000 per year for up to two years. The foundation prioritizes research with a translational or preclinical focus, encouraging applications from global institutions. By addressing key bottlenecks in research, FRAXA fosters innovative strategies to validate and implement promising therapies, ultimately benefiting individuals affected by Fragile X and related conditions like autism and Alzheimer's.
FRAXA Research Foundation Inc

Up to US $5,000,000

Drug Development RFP

Full proposal due Dec 7, 2026
The Drug Development RFP by the Alzheimer's Drug Discovery Foundation invites innovative proposals for early-phase clinical trials targeting Alzheimer's disease and related dementias. This funding prioritizes diverse drug mechanisms, excluding amyloid-targeted and cholinesterase inhibitors. Eligible applicants include academic institutions and biotechnology firms, with funding up to $5 million. The focus is on novel therapies and comprehensive analyses of mechanisms of action, encouraging partnerships to enhance research outcomes.
Alzheimers Drug Discovery Foundation

Up to US $600,000

Neuroimaging and CSF Biomarker RFP

Full proposal due Dec 7, 2026
This grant opportunity focuses on advancing biomarkers for Alzheimer's disease and related dementias, emphasizing those with a clear clinical application and commercialization potential. It encourages the development of novel PET ligands, CSF biomarkers, and innovative MRI techniques, alongside exploring neuroinflammation, synaptic integrity, and protein misfolding. Researchers from academic institutions and biotechnology companies are invited to apply, with funding of up to $600,000 available for promising projects.
Alzheimers Drug Discovery Foundation

Up to US $50,000

Regional Delivery Grants

Applications due Oct 15, 2026
The Oligonucleotide Therapeutics Society (OTS) fosters research and development in oligonucleotide therapeutics through its Regional Delivery Grants. These grants support regional meetings outside of the US, Europe, and Canada, enabling knowledge sharing and professional development among researchers. By promoting networking and collaboration, OTS aims to broaden its reach and impact in the global oligonucleotide research community. Applications are accepted on a rolling basis and reviewed biannually, emphasizing innovative event formats.
Oligonucleotide Therapeutics Society

Up to US $1,000,000

The Esther Tomljanovich Strategic Initiatives

Full proposal due May 1, 2027
The Esther Tomljanovich Strategic Initiatives grant from the Medica Foundation supports transformative projects aimed at advancing health equity. With a funding capacity of up to $200,000 over two to three years, the initiative focuses on innovative proposals in healthcare workforce development, women's health, aging services, dental programs, and housing stability. Grantees are expected to demonstrate measurable outcomes and foster collaboration within their communities, emphasizing the importance of addressing unique health needs.
Medica Foundation

US $130,000

AFTD Holloway Fellowships

Full proposal due Nov 21, 2026
The AFTD Holloway Fellowships, initiated in 2021, offer $60,000 per year for two years to support innovative research on frontotemporal degeneration (FTD). Open to postdoctoral scientists globally, these fellowships aim to advance understanding of FTD disorders, including primary progressive aphasia and FTD-ALS. Projects addressing cellular mechanisms, novel diagnostic technologies, and health disparities in FTD research are particularly encouraged, promoting significant contributions to this critical field.
The Association For Frontotemporal Degeneration

Up to US $7,500,000

Alzheimer's Drug-Development Program (Clinical Trial Optional)

Applications due Nov 5, 2026
The Alzheimer's Drug-Development Program aims to support the development of innovative small-molecule and biologic drug candidates that can prevent, slow, or treat Alzheimer's disease and its symptoms. Application deadlines span from February 2025 to October 2027, with optional Letters of Intent due 30 days prior to each deadline. This funding opportunity is provided by the US Department of Health & Human Services through the National Institutes of Health.
US Dept. of Health & Human Services: National Institutes of Health (NIH)

Up to US $50,000

Alzheimer’s Disease Pre-Clinical Translational Science Grant

Applications due Jul 7, 2027

The goal of Alzheimer’s Disease Pre-Clinical Translational Science Grant program is to enhance our approach to the selection and prosecution of drug discovery targets for Alzheimer’s Disease. This mechanism will provide research support up to $50,000 for innovative work that is in scope and aligned with the research activities of the IUSM-Purdue TREAT-AD Center. These include (but are not limited to):

  • Bioinformatic analyses and drug target hypothesis generation within neuroinflammatory pathways.
  • Target validation studies for proposed drug targets.
  • Innovative chemical biology and cellular pharmacology studies for proposed targets that may provide insights to disease initiation and progression.
  • Structural biology or biophysical studies on proteins proposed as drug targets.
  • De-novo drug design approaches for proposed targets.
  • Novel PET ligands and supporting CSF biomarkers for preclinical studies and clinical trials, etc. 
Indiana Clinical and Translational Sciences Institute (CTSI)

Approximately US $100,000

NIA Advanced Postdoctoral Career Transition Awards to Promote Diversity in Translational Research for AD/ADRD (K99/R00 Clinical Trial Not Allowed) (356315)

Applications due Oct 12, 2026
The NIA Advanced Postdoctoral Career Transition Awards aim to enhance diversity in the translational research workforce for Alzheimer's disease and related dementias (AD/ADRD). This initiative supports early career researchers from diverse backgrounds in acquiring essential research skills applicable to various AD/ADRD studies. The goal is to cultivate a more diverse pool of researchers capable of leading interdisciplinary approaches in treatment, prevention, and management of AD/ADRD. Notably, independent clinical trials are not permitted under this award.
US Dept. of Health & Human Services: National Institutes of Health (NIH)

Up to US $150,000

NIA Academic Leadership Career Award (K07 Independent Clinical Trial Not Allowed) (357000)

Applications due Oct 12, 2026
The NIA Academic Leadership Career Award (K07) provides funding for established investigators to strengthen research capacity in aging and Alzheimer's Disease. The program supports the development of educational infrastructure, mentorship, and career development activities. Key deadlines for applications include February 12, June 12, and October 12 from 2025 to 2027. This award is specifically for research not involving independent clinical trials, allowing applicants to gain experience in trials led by others.
US Dept. of Health & Human Services: National Institutes of Health (NIH)

Up to US $375,000

Academic Research Enhancement Award (AREA) for Undergraduate-Focused Institutions (R15 Clinical Trial Not Allowed) (357458)

Applications due Oct 25, 2026
The Academic Research Enhancement Award (AREA) supports small-scale research grants for institutions with limited NIH funding, emphasizing biomedical research experiences for undergraduates. Eligible institutions must award baccalaureate science degrees and have received no more than $6 million in NIH support over the past seven years. This initiative aims to enhance the research environment at these institutions, fostering student involvement in research activities.
US Dept. of Health & Human Services: National Institutes of Health (NIH)

Up to US $5,000,000

Translational Bioinformatics and Experimental Approaches to Advance Drug Repositioning and Combination Therapy Development for Alzheimer's Disease and Related Dementias (R01 Clinical Trial Not Allowed)

Applications due Oct 6, 2026
This funding opportunity seeks applications that leverage mouse models for comprehensive preclinical testing of drugs or combinations currently approved for other conditions, as well as investigational drugs showing promise against Alzheimer's Disease (AD) and related dementias (ADRD). The initiative aims to facilitate proof of concept studies that promote rational drug repurposing and the development of combination therapies, thereby enhancing treatment and prevention strategies for AD/ADRD.
US Dept. of Health & Human Services: National Institutes of Health (NIH)

Showing 27 of 119 results.

Sign up to see the full list

Alzheimer's and Dementia Research Grants Highlights

Seeking Alzheimer's and dementia research grants for your medical studies or projects? We list a variety of available grants. From clinical research to caregiving strategies and awareness campaigns, Instrumentl’s database keeps you updated with active grants.

Start your 14-day free trial to access opportunities for Alzheimer's and dementia research.

Last updated: October 5, 2026. Next update: November 1, 2026.

Grant Insights : Alzheimer's and Dementia Research Grants

Grant Availability

How common are grants in this category?

Uncommon — grants in this category are less prevalent than in others.

100+ Alzheimer's and Dementia Research Grants grants for nonprofits in the United States, from private foundations to corporations seeking to fund grants for nonprofits.

59 Alzheimer's and Dementia Research Grants over $25K in average grant size

51 Alzheimer's and Dementia Research Grants over $50K in average grant size

10 Alzheimer's and Dementia Research Grants supporting general operating expenses

51 Alzheimer's and Dementia Research Grants supporting programs / projects

100+ Grants on Instrumentl focused on Dementia & Alzheimer’s Disease

200+ Grants on Instrumentl focused on Aging / Gerontology

Grant Deadline Distribution

Over the past year, when are grant deadlines typically due for Alzheimer's and Dementia Research grants?

Most grants are due in the fourth quarter.

Q1
26.4%
Q2
22.4%
Q3
20.2%
Q4
31.0%

Typical Funding Amounts

What's the typical grant amount funded for Alzheimer's and Dementia Research Grants?

Grants are most commonly $75,000.

$750 $750 Min.
$75,000 $75 K Median
$319,888 $319.9 K Average
$3,750,000 $3.8 M Max.

Frequently asked questions

Alzheimer’s and dementia research grants are open to research institutions, universities, medical centers, and nonprofits focused on studying these diseases. Many of these grants also encourage collaboration between scientists, physicians, and advocacy groups to speed up progress. While some grants focus solely on clinical or laboratory research, other groups that support public health initiatives, caregiver support programs, and community-based interventions may also be eligible to receive funding.

Based on Instrumentl’s live grant database for Alzheimer's and dementia research, grant deadlines are most common in Q4, accounting for 31.0% of all submission dates. The slowest period for new grant opportunities in this category falls in Q3, making it a less competitive time for preparation and strategic planning.

Alzheimer’s and dementia research grants go beyond just searching for a cure—they support early detection, improved treatments, and more support for caregivers. Funders invest in projects that explore the causes of these diseases, develop new therapies, and improve patient care. These grants may also contribute to caregiver training and support programs, ensuring that both patients and those caring for them receive the help they need.

Funding for Alzheimer's and dementia research grants varies widely, with award amounts ranging from a minimum of $750 to a maximum of $3,750,000. Based on Instrumentl’s data, the median grant amount for this category is $75,000, while the average grant awarded is $319,888. Understanding these funding trends can help nonprofits set realistic expectations when applying.

Alzheimer’s and dementia research grants are backed by major organizations such as The National Institute on Aging (NIA), Alzheimer’s Association, and the BrightFocus Foundation. In some cases, individual donors with a passion for neurological research fund these grants as well. Universities and medical research institutions may also have internal grant programs dedicated to advancing Alzheimer’s and dementia studies.

To improve the chances of getting Alzheimer's and dementia research grants, applicants should:

  • Align your project with the funder’s priorities – Show how your project matches a funder’s specific focus areas, whether it’s clinical research, early diagnosis, or patient care.
  • Demonstrate real-world impact and use data – Prove how your work will improve patient outcomes, enhance treatments, or contribute to scientific breakthroughs. Use solid data when you can to further show current and potential impact.
  • Collaborate with top experts – Partnering with well-respected researchers, clinicians, or institutions can improve your chances.
  • Get institutional support – Letters of endorsement from universities, hospitals, or research centers can strengthen your application.

Want to improve your grant prospecting strategy? Master the process with our detailed guide to grant prospect research.

Instrumentl simplifies the process of applying for Alzheimer's and dementia research grants by offering an intuitive platform that helps nonprofits discover relevant funding opportunities, track deadlines, and analyze funder-giving patterns. The platform's automated alerts ensure users never miss a deadline, while detailed funder insights help organizations tailor their applications to align with grantor priorities.

To learn more about how our platform is different, compare Instrumentl to other grant tools.

Filter Alzheimer's and Dementia Research Grants

Browse Alzheimer's and Dementia Research Grants by Location

Related Grant Funding Focus Areas

Browse Other Health & Wellness Grants